PAVM חוב כולל להון PAVmed, Inc.

PAVmed Inc. (PAVM) operates as a diversified medtech holding company, competing with niche tech giants across various segments. The company's financial position is complicated by debts within its cancer diagnostics divisions and uncertainty regarding insurance reimbursements. The business relies on outsourcing sensor production while retaining intellectual property rights. This price chart reflects the total debt-to-equity ratio, which currently stands at 0.52.

This ratio measures the degree of business dependence on borrowed funds by comparing total liabilities to equity to assess financial stability and bankruptcy risks. By analyzing changes in the total debt-to-equity ratio, an investor can evaluate how effectively PAVmed Inc. finances the development of the EsoGuard diagnostic ecosystem and expansion into the Medicare segment without incurring an excessive debt load.